Michael E. Severino

2017

In 2017, Michael E. Severino earned a total compensation of $8.4M as Executive Vice President, Research & Development and Chief Scientific Officer at AbbVie, a 16% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$653,582
Non-Equity Incentive Plan$1,955,069
Option Awards$980,980
Salary$1,004,460
Stock Awards$3,681,906
Other$119,279
Total$8,395,276

Severino received $3.7M in stock awards, accounting for 44% of the total pay in 2017.

Severino also received $653.6K of change in pension value and nonqualified deferred compensation earnings, $2M in non-equity incentive plan, $981K in option awards, $1M in salary and $119.3K in other compensation.

Rankings

In 2017, Michael E. Severino's compensation ranked 882nd out of 14,666 executives tracked by ExecPay. In other words, Severino earned more than 94.0% of executives.

ClassificationRankingPercentile
All
882
out of 14,666
94th
Division
Manufacturing
299
out of 5,772
95th
Major group
Chemicals And Allied Products
76
out of 2,075
96th
Industry group
Drugs
53
out of 1,731
97th
Industry
Pharmaceutical Preparations
43
out of 1,333
97th
Source: SEC filing on March 19, 2018.

Severino's colleagues

We found four more compensation records of executives who worked with Michael E. Severino at AbbVie in 2017.

2017

Richard Gonzalez

AbbVie

Chief Executive Officer

2017

Laura Schumacher

AbbVie

General Counsel

2017

Carlos Alban

AbbVie

Executive Vice President, Global Commercial Operations

2017

William Chase

AbbVie

Chief Financial Officer

News

You may also like